全文获取类型
收费全文 | 1676820篇 |
免费 | 137904篇 |
国内免费 | 2764篇 |
专业分类
耳鼻咽喉 | 22624篇 |
儿科学 | 55284篇 |
妇产科学 | 47869篇 |
基础医学 | 238624篇 |
口腔科学 | 48889篇 |
临床医学 | 150567篇 |
内科学 | 327741篇 |
皮肤病学 | 35539篇 |
神经病学 | 136761篇 |
特种医学 | 67082篇 |
外国民族医学 | 480篇 |
外科学 | 252755篇 |
综合类 | 40962篇 |
现状与发展 | 3篇 |
一般理论 | 624篇 |
预防医学 | 131856篇 |
眼科学 | 37954篇 |
药学 | 126945篇 |
4篇 | |
中国医学 | 3063篇 |
肿瘤学 | 91862篇 |
出版年
2018年 | 16551篇 |
2016年 | 14345篇 |
2015年 | 16559篇 |
2014年 | 22639篇 |
2013年 | 34363篇 |
2012年 | 46638篇 |
2011年 | 49065篇 |
2010年 | 28597篇 |
2009年 | 27369篇 |
2008年 | 46407篇 |
2007年 | 48927篇 |
2006年 | 49498篇 |
2005年 | 48153篇 |
2004年 | 47317篇 |
2003年 | 45181篇 |
2002年 | 44140篇 |
2001年 | 77423篇 |
2000年 | 80061篇 |
1999年 | 68019篇 |
1998年 | 18659篇 |
1997年 | 17047篇 |
1996年 | 17011篇 |
1995年 | 16632篇 |
1994年 | 15697篇 |
1993年 | 14763篇 |
1992年 | 56698篇 |
1991年 | 55020篇 |
1990年 | 53713篇 |
1989年 | 51909篇 |
1988年 | 48292篇 |
1987年 | 47612篇 |
1986年 | 45245篇 |
1985年 | 43826篇 |
1984年 | 32900篇 |
1983年 | 28360篇 |
1982年 | 16724篇 |
1981年 | 14946篇 |
1980年 | 14005篇 |
1979年 | 31201篇 |
1978年 | 21647篇 |
1977年 | 18252篇 |
1976年 | 17183篇 |
1975年 | 18054篇 |
1974年 | 22022篇 |
1973年 | 21141篇 |
1972年 | 19312篇 |
1971年 | 18168篇 |
1970年 | 16684篇 |
1969年 | 15640篇 |
1968年 | 14293篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
F. Murina R. Felice S. Di Francesco L. Nelvastellio I. Cetin 《Gynecological endocrinology》2020,36(5):431-435
AbstractThis study is a single-center, retrospective analysis of postmenopausal women presenting with dyspareunia and vulvar pain, aiming to evaluate relative effectiveness of vestibular CO2 laser therapy as a treatment. Three monthly sessions of laser were performed to each patient and thereafter a three-months follow-up was stablished. A total number of 72 patients undergoing vestibular laser treatment were recruited from patient files in the period between 2016 and 2018. Among these, 39 women also received a concomitant treatment with ospemifene (60?mg/day) during the study period. There was a statistically significant reduction of all the symptoms in both groups up to the three month follow-up. Regarding dryness and dyspareunia, the relief tent to be more prominent in the ospemifene?+?laser group at all follow-ups and remained statistically significant at three-month follow-up. Specifically, vestibular dryness was significantly lower in the ospemifene?+?laser group compared with the laser treatment group (?87% vs???34%, respectively), and the vestibular health score started declining faster in the ospemifene?+?laser group. Although, additional research is needed to understand the mechanism of action, our data shows that a combination regimen of laser and ospemifene may improve clinical effectiveness for long-term treatment of symptoms associated with the under-recognized genitourinary syndrome of menopause. 相似文献
82.
Melanoma is a deadly tumor, which in recent years has been successfully treated with immune checkpoint inhibitors as PD-1/PD-L1 and CTLA-4 inhibitors and targeted therapy as BRAF and MEK inhibitors. However, immunotherapy poses deleterious side effects and pursuit of new therapeutic targets is warranted. As knowledge of tumor immunology advances, such targets are being recognized. C-motif chemokine receptor-5 (CCR5) is a receptor found on immune cells whose effects impact the immune response both to induce inflammation and to activate suppressor cells causing an anti-inflammatory effect. CCR5 is well known as a target for HIV therapy where its blockade is efficient and safe, it is also known that its mutation CCR5delta32 is for the most part non-pathological to its carriers. In oncology, activation of the CCR5 receptor has been observed in high-stage disease and CCR5 blockade has been associated with an increased immune response. In this letter, we build up the rationale to utilize CCR5 as a therapeutic target for metastatic melanoma. 相似文献
83.
84.
85.
86.
Changes in Right Ventricular Shape and Deformation Following Coronary Artery Bypass Surgery—Insights from Echocardiography with Strain Rate and Magnetic Resonance Imaging 下载免费PDF全文
87.
88.
Tobias Kisch Julia Maria Klemens Katharina Hofmann Eirini Liodaki Matthias Gierloff Dirk Moellmeier Felix Stang Peter Mailaender Jens Habermann Matthias Brandenburger 《Medicine》2015,94(41)
The regrowth of amputated digit tips represents a unique regenerative healing in mammals with subcutaneous volume regrowth, restoration of dactylogram, and suppression of scar formation. Although factor analysis in amphibians and even in mice is easy to obtain, safety of harvesting biomaterial from human digit tip amputations for analysis has not yet been described.The aim of this study was to evaluate if recovering wound exudate does hamper clinical outcome or influence microbiologic or inflammation status.A predefined cohort of 18 patients with fresh digit tip amputations was randomly assigned to receive standard therapy (debridement, occlusive dressing) with (n = 9) or without (n = 9) collection of the whole wound exudate in every dressing change. Primary endpoint (lengthening) and secondary endpoints (regeneration of dactylogram, nail bed and bone healing, time to complete wound closure, scar formation, 2-point discrimination, microbiologic analysis, inflammatory factors interleukin (IL)-1α, tumor necrosis factor-α, IL-4, and IL-6) were determined by an independent, blinded observer.Patients’ characteristics showed no significant differences between the groups. All patients completed the study to the end of 3 months follow-up. Exudate collection did not influence primary and secondary endpoints. Furthermore, positive microbiologic findings as well as pus- and necrosis-like appearance neither impaired tissue restoration nor influenced inflammatory factor release.Here, the authors developed an easy and safe protocol for harvesting wound exudate from human digit tip amputations. For the first time, it was shown that harvesting does not impair regenerative healing. Using this method, further studies can be conducted to analyze regeneration associated factors in the human digit tip.DRKS.de Identifier: DRKS00006882 (UTN: U1111-1166-5723). 相似文献
89.
90.